SUSQUEHANNA INTERNATIONAL GROUP, LLP - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 28 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$239,241
-96.5%
37,265
-96.0%
0.00%
-100.0%
Q1 2023$6,894,007
+118.7%
925,370
+28.3%
0.00%0.0%
Q4 2022$3,151,644
-12.1%
721,200
+13.0%
0.00%0.0%
Q3 2022$3,586,000
-31.7%
638,000
-29.9%
0.00%0.0%
Q2 2022$5,249,000
-40.5%
909,700
+4.5%
0.00%0.0%
Q1 2022$8,827,000
-31.5%
870,500
-44.1%
0.00%
Q4 2021$12,894,0001,557,2000.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 136,593$1,106,0000.35%
Total Clarity Wealth Management, Inc. 11,425$93,0000.04%
Virtu Financial LLC 32,952$267,0000.02%
Apollon Wealth Management, LLC 19,400$157,0000.02%
Summit Trail Advisors, LLC 35,000$284,0000.02%
FNY Investment Advisers, LLC 4,687$37,0000.02%
Freedom Investment Management, Inc. 16,649$135,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 156,946$1,271,0000.01%
Belvedere Trading LLC 13,608$107,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 10,000$81,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders